Business
SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company's Total Number of Active Patents and Patent Applications to 150
Patents and patent applications provide additional coverage for the company's shockwave and ultrasound technologies in medical and non-medical fieldsSUWANEE,
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"Patents and patent applications provide additional coverage for the company's shockwave and ultrasound technologies in medical and non-medical fieldsSUWANEE, GA / ACCESSWIRE / May 11, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of 2021.SANUWAVE continues to invest in the development of the company's technologies and the associated intellectual property with such advances. The patent applications for SANUWAVE continued to grow in 2020, despite the difficult year for many. SANUWAVE has multiple initiatives underway to further develop and monetize the company's non-wound care patents.For the shockwave technology incorporated in the dermaPACE® and orthoPACE® Systems the following new patents were issued:US 10,562,793 titled \"Systems and Methods for Separating Heavy Water from Normal Water Using Acoustic Pressure Shock Waves\". This US patent covers the systems and methods used to separate heavy water from normal water form nuclear power plants. The patent has 20 claims and it will expire in August 08, 2036.US 10,569,106 titled \"Tissue Disinfection with Acoustic Pressure Shock Waves\". This US patent covers the medical systems that can be used for infection treatments for a protruding appendage of a human or animal body affected by harmful pathogens as bacteria, viruses, funguses and other micro-organisms. This patent is specifically related to treatment of an infected toe, finger, tail, nose, or a bovine, ovine and caprine teat or udder, to eliminate infection and its delirious effects. The patent has 19 claims and it will expire in September 28, 2038.US 10,639,051 titled \"Occlusion and Clot Treatment with Intracorporeal Pressure Shock Waves\", covers the medical systems that can be used for the treatment with our technology of possible occlusions and blood clots for blood vessels. This is an intracorporeal approach using a catheter-based system, which has at its distal end shockwave elements able to direct their energy towards vessel occlusion or blood clots. The patent has 20 claims and it will expire in September 29, 2031.US 10,...